These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
69 related items for PubMed ID: 8492011
21. [Serodiagnostic tests by factor analysis and stepwise discriminating analysis with tumor markers for the detection of ovarian cancer]. Kobayashi H, Sumimoto K, Terao T, Kawashima Y. Nihon Sanka Fujinka Gakkai Zasshi; 1989 Dec; 41(12):1903-10. PubMed ID: 2480396 [Abstract] [Full Text] [Related]
23. [The sensitivity of the CA125 immunoradiometric assay for patients with epithelial ovarian cancer and its correlation with complex treatment]. Shi W, Zhang YJ, Jiang CY. Zhonghua Fu Chan Ke Za Zhi; 1994 Oct; 29(10):604-6, 637-8. PubMed ID: 7712875 [Abstract] [Full Text] [Related]
27. [Clinical value of a new serum tumor marker CA602 in ovarian cancers]. Suzuki M, Sekiguchi I, Ohwada M, Aida I, Tamada T. Nihon Gan Chiryo Gakkai Shi; 1990 Jul 20; 25(7):1454-60. PubMed ID: 2170549 [Abstract] [Full Text] [Related]
29. [Analysis of CA 125 assay system and its diagnostic significance in gynecologic tumors]. Shimizu Y, Akagaki E, Hirota K, Kono M, Miura S, Okudaira Y. Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec 20; 37(12):2813-20. PubMed ID: 3866801 [Abstract] [Full Text] [Related]
30. [The clinical usefulness of serum CA72-4 analysis in patients with ovarian cancer]. Kobayashi H. Nihon Sanka Fujinka Gakkai Zasshi; 1989 May 20; 41(5):585-9. PubMed ID: 2754289 [Abstract] [Full Text] [Related]
31. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis]. Chen F, Li WM, Wang DM, Gao SS, Bao Y, Chen WB, Liu D. Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep 20; 39(5):832-5. PubMed ID: 19024326 [Abstract] [Full Text] [Related]
32. Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer. Dieplinger H, Ankerst DP, Burges A, Lenhard M, Lingenhel A, Fineder L, Buchner H, Stieber P. Cancer Epidemiol Biomarkers Prev; 2009 Apr 20; 18(4):1127-33. PubMed ID: 19336561 [Abstract] [Full Text] [Related]
36. Significance of some tumor markers in differential diagnosis of ovarian tumor. Zakrzewska I, Borawska R, Poznański J, Maćkowiak B. Rocz Akad Med Bialymst; 1999 Apr 20; 44():235-43. PubMed ID: 10697438 [Abstract] [Full Text] [Related]
37. Circulating mucins as tumor markers in ovarian cancer (review). Devine PL, McGuckin MA, Ward BG. Anticancer Res; 1992 Apr 20; 12(3):709-17. PubMed ID: 1622128 [Abstract] [Full Text] [Related]
38. [Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (second report)--clinical significance of GAT and comparison with other tumor markers]. Nozawa S, Udagawa Y, Ito K, Susumu N, Sasaki H, Aoki D. Gan To Kagaku Ryoho; 1993 Feb 20; 20(2):279-85. PubMed ID: 8434967 [Abstract] [Full Text] [Related]
39. IMMULITE OM-MA assay: a useful diagnostic tool in patients with benign and malignant ovarian tumors. Gebauer G, Rieger M, Jäger W, Lang N. Anticancer Res; 1999 Feb 20; 19(4A):2535-6. PubMed ID: 10470190 [Abstract] [Full Text] [Related]